Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Remote coaching helps breast cancer survivors get active and feel better

NCT ID NCT04536584

Symptom relief Sponsor: Centre Oscar Lambret Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether personalized remote exercise coaching, using a digital platform and a connected watch, could improve quality of life in 824 breast cancer survivors. Participants were randomly assigned to receive either the coaching or standard advice. The study measured changes in physical and mental health scores after 12 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
personalized physical activity coaching via digital platform and connected watch
What this could lead to
If it works, this could show that remote exercise support helps breast cancer survivors feel better and have a higher quality of life after treatment.
What could go wrong
This is a completed study, but the results may not apply to all survivors. The benefit may be small or not meaningful for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

824 people

The number who actually took part.

Started

Dec 2020

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient ≥18; * Diagnosis of invasive non-metastatic breast cancer; * 5 months (+/- 3 months) after the end of the treatment by surgery and/or radiotherapy and/or chemotherapy and/or other "short-term" systemic treatment : immunotherapy, PARP inhibitor, trastuzumab or TDM1 ; the continuation of hormonotherapy (more or less associated with an anti-CDK4/6), trastuzumab or TDM1 is possible during the study period; * SF-36 filled in completely * Medical certificate for sports practice delivered by a healthcare professional or oncologist. Neither the previous sports practice, nor the motivation for the proposed program is necessary to participate in the program. * Agreement for follow-ups during the study period lasting 12 months; * Ability to understand, read and write French; * Patient covered by the French "Social Security" regime; * Signed informed consent for the participation in the study, including the randomization with a 50%/50% chance of being allocated to one or the other group. Exclusion Criteria: * Relapse of invasive breast cancer (loco-regional relapse, contralateral relapse) * Inability to exercise because of a severe handicap or vulnerability. These contraindications are left to the discretion of the healthcare professional assessing capacity (ex : severe malnutrition, pregnancy …); * Metastatic cancer; * Expressed preference for one arm; * Inability to comply with follow-up (4 and 12 months) of the trial (geographical, social, medical or psychological reasons); * Person under guardianship or curatorship.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer female breast carcinoma Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer female

Contacts and locations

Locations

  • CARIO Hôpital Privé des Côtes d'Armor

    Plérin, Brittany Region, 22190, France

  • CH de Boulogne-sur-Mer

    Boulogne-sur-Mer, Hauts-de-France, 62321, France

  • CH de Roubaix

    Roubaix, Hauts-de-France, 59056, France

  • CH de Valenciennes

    Valenciennes, Hauts-de-France, 59322, France

  • Centre Eugène marquis

    Rennes, Brittany Region, 35042, France

  • Centre Gray-Amethyst Radiothérapie

    Maubeuge, Hauts-de-France, 59600, France

  • Centre Hospitalier Eure-Seine - Hôpital d'Evreux

    Évreux, Normandy, 27015, France

  • Centre Joliot Curie

    Saint-Martin-Boulogne, Hauts-de-France, 62280, France

  • Centre Léon Bérard

    Lyon, Auvergne-Rhône-Alpes, 69379, France

  • Centre Marie Curie

    Arras, Hauts-de-France, 62000, France

  • Centre Oscar Lambret

    Lille, Hauts-de-France, 59020, France

  • Centre Pierre Curie

    Beuvry, Hauts-de-France, 62660, France

  • Centre d'oncologie et radiothérapie Saint-Jean

    Saint-Doulchard, Centre-Val de Loire, 18230, France

  • Centre de cancérologie Les Dentellières

    Valenciennes, Hauts-de-France, 59300, France

  • Centre de radiothérapie Amethyst

    Compiègne, Hauts-de-France, 60200, France

  • Groupe Hospitalier Bretagne Sud

    Lorient, Brittany Region, 56100, France

  • Hôpital Privé du Confluent

    Nantes, Pays de la Loire Region, 44277, France

  • Institut André Dutreix

    Dunkirk, Hauts-de-France, 59240, France

  • Institut Bergonié

    Bordeaux, New Aquitaine, 33076, France

  • Institut Gustave Roussy

    Villejuif, Île-de-France Region, 94800, France

  • Polyclinique Bordeaux Nord Aquitaine

    Bordeaux, New Aquitaine, 33077, France

  • Sainte Catherine Institut du Cancer Avignon Provence

    Avignon, France, 84918, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.